DNA polymerase beta overexpression correlates with poor prognosis in esophageal cancer patients by Hong Zheng et al.
   
 
© The Author(s) 2013. This article is published with open access at Springerlink.com csb.scichina.com   www.springer.com/scp 
                      
†These authors contributed equally to this work. 
*Corresponding authors (email: zhaogq@zzu.edu.cn; dongzm@zzu.edu.cn) 
Article 
Preclinical Medicine September 2013  Vol.58  No.26: 32743279 
 doi: 10.1007/s11434-013-5956-2  
DNA polymerase beta overexpression correlates with poor prognosis 
in esophageal cancer patients  
ZHENG Hong1†, XUE Peng1†, LI Min2, ZHAO JiMin2, DONG ZiMing2* & ZHAO GuoQiang2* 
1 Department of Pathophysiology, Medical College of Henan University, Kaifeng 475004, China;  
2 School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China 
Received March 26, 2013; accepted May 17, 2013; published online July 17, 2013 
 
Gene of DNA polymerase beta (pol) plays an important role in base excision repair, DNA replication and translesion synthesis. 
This study aims to investigate the expression and prognostic significance of DNA pol in esophageal cancer. DNA pol expres-
sion was analyzed using real-time quantitative PCR (RT-qPCR) and immunohistochemical staining on tissue samples from a 
consecutive series of 114 esophageal squamous carcinoma patients who underwent resections between 2002 and 2006. Pol ex-
pression was investigated on its correlation to clinico-pathological factors and survival. RT-qPCR results showed higher expres-
sion of DNA pol mRNA in tumor tissue than in its matched adjacent non-tumor tissue sample, different expression of DNA pol 
mRNA was noticed with significance between tumors with and without lymph node metastasis. Immunohistochemistry staining 
results indicated the pol strong-positive rate was 44.73% (51/114) in tumor tissue samples and 0.00% in matched adjacent 
non-tumor tissue samples, with significant difference. Kaplan-Meier survival curves revealed that high expression of pol was 
associated with tumor metastasis and poor prognosis in esophageal cancer patients. Our data suggests that pol plays an important 
role in tumor progression and that high pol expression predicts an unfavorable prognosis in esophageal squamous carcinoma 
patients. 
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Esophageal cancer (EC), one of the most common malig-
nancies threatening human health, is characterized in the 
significant difference in regional distribution in epidemiol-
ogy. EC patients newly diagnosed each year in China ac-
count for more than half of all EC cases across the world 
[1,2]. Another important feature of EC is its high mortality, 
most EC patients succumb to metastasis and eventual death 
despite of radical resection and multi-modality therapies 
applied [3,4]. 
In tumor molecular genetics, it is well-known that car-
cinogenesis is a multi-stage process with variation in multi-
ple genes. Endogenous or exogenous detrimental factors 
may induce DNA damage and mutation constituting the 
genetic basis of neoplastic pathogenesis. DNA polymerase 
beta (pol), found widely in nucleus of mammalian cells, is 
a small-molecular protein (Mr: 39 kD) with a single peptide 
chain. Consisting of 355 amino acid residues, this small 
DNA polymerase plays a vital role in base excision repair, 
DNA replication and translesion synthesis [5–7]. Given its 
poor fidelity in synthesizing DNA, pol may be one of the 
causes of genomic instability when it is highly expressed 
and therefore participates probably in DNA replication, 
permits the duplication of the mistaken DNA, and induces 
mutation in a static cell [8,9]. Recent researches imply that 
the obviously higher expression of pol correlates closely to 
carcinogenesis and development either in vivo or in vitro in 
multiple malignancies [10–12]. Our study is the first to re-
port that DNA pol correlates with worse survival of EC 
patients, which may provide a new idea for prevention and 
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treatment of EC.  
1  Materials and methods  
1.1  Patients and samples 
EC samples (114 samples) were collected after esophagec-
tomy from 3 hospitals including Oncology Hospital of Lin-
zhou, People’s Hospital of Linzhou and the 1st Hospital 
Affiliated to Zhengzhou University. All tumors were histo-
pathologically confirmed to be squamous cell carcinoma 
and none of patients have received any therapies before 
surgery. The mean age of EC in our study was 59.56±8.67. 
The matched adjacent esophageal mucosae samples at least 
5 cm away from the tumor borderline were collected as well. 
All samples were snap-frozen and kept in liquid nitrogen. 
All patients signed the informed consent before collecting 
samples. This study was approved by Ethical Committee of 
Zhengzhou University.  
1.2  Real-time quantitative PCR (RT-qPCR) analysis  
Total RNA was extracted from EC and matched adjacent 
tissue samples using TRIZOL (Invitrogen, CA). Reverse 
transcription was performd with 6 L 5×Buffer, 1 L RNasin, 
2 L 4×dNTP (2.5 mmol L1), 1 L Oligo6 (10 mol L1), 
1 L AMV (10 U L1), 5 L RNA template and 14 L 
DEPC water according to protocols provided by the supplier. 
Quantitative real-time PCR was carried out in a 50-L reac-
tion system including 25 L 2×SYBR® Premix Ex Taq en-
zyme (TaKaRa, Japan), 1 L forward and 1 L reverse 
primer for pol (5′-ACGTAAACTGGAAAAGATTCGGC- 
3′, 5′-GCCCAATTCGCTGATGATGGTTC-3′), 1 L 50× 
ROX Reference Dye (Roche, USA), 4 L cDNA template, 
18 L DEPC water. PCR parameters included pre-denature 
at 95°C for 3 min, 95°C for 20 s and 60°C for 60 s for 40 
cycles, and terminal extension for 10 min. The primers for 
-actin were 5′-TGACCCAGATCATGTTTGAG-3′ and 
5′-TGGCATGGGGGAGGGCATAC-3′ for sense and anti- 
sense respectively. The amplified CT value was recorded to 
quantify the copies of the gene. The copy ratio of pol and 
-actin were presented as the relative expression of pol. 
1.3  Immunohistochemistry assay 
One hundred and fourteen EC and matched adjacent tissue 
samples were fixed with 10% neutral methanol, embedded 
with paraffin and cut into 5 m slides for IHC (immuno-
histochemistry) analysis. IHC was performed using strep-
tavidin-perosidase method (SP method) according to in-
struction provided by the supplier. Rabbit anti-human pol 
antibody from Santa Cruz (sc-48819)was used at 1:300 
working concentration. The slides after 1st and 2nd antibody 
was developed with DAB, re-stained with hematoxylin, 
dehydrated, hyalinized, and sealed. Negative control was 
done with normal rabbit serum instead of 1st antibody and 
blank control was done with PBS. For immunostaining scor-
ing, 10 high power fields were chosen randomly to count a 
total of 100 cells in each field. For the percentage of posi-
tive cells, it was negative or “0” if positive cells less than 
5%, 1 for 6%–25%, 2 for 26%–50%, 3 for 51%–70%, and 4 
for >75%. For intensity evalution, it was “0” for negative 
staining, 1 for cells stained lemon yellow, 2 for yellow, and 3 
for pale brown. The product of the two scores was classified 
into four levels: the negative for product 0, weak positive (+) 
for 1–4, positive (++) for 5–8, strong positive (+++) for 
9–12.   
1.4  Follow-up of EC patients 
All patients after surgery were followed up. The overall 
survival was defined as the period from surgery to last fol-
low up, or to death. The follow up ended at June 2012 with 
a mean follow-up period of 59.2 months. 
1.5  Statistical analysis 
SPSS 17.0 was used for statistical analysis. Data obtained 
was presented as mean ± standard deviation( x ±SD). T-test 
was used to compare the average of two samples. Chi-square 
test was used to compare the ratio of the two samples. Lo-
gistic regression analysis was used to evaluate the correlation 
of pol mRNA with lymph node metastasis in EC. Kaplan- 
Meier analysis was used to plot the curve of survival. Cox 
model was used for the multiple-factor prognostic analysis. 
P-value of less than 0.05 was considered as significant.  
2  Results  
2.1  Pol mRNA expression in EC 
Using RT-qPCR, we measured pol mRNA expression in 
114 EC and matched adjacent esophageal tissue. The pol 
mRNA expression in EC (0.440±0.049) was significantly 
higher than the level of esophageal mucosae (0.148±0.020) 
(t=58.37, P<0.001). In EC with lymph node metastasis, 
furthermore, the level of pol mRNA expression increased 
significantly as well compared with EC without lymph node 
involvement (P<0.001). In different stages of EC (TNMG I, 
II, III), the difference of pol mRNA is significant (P< 
0.001). There was no difference between age and sex (P> 
0.05) (Figure 1).  
2.2  Pol protein expression in EC 
We performed IHC for 114 EC and matched adjacent esoph-
ageal tissue samples. The immunoreactivity of pol was 
yellow to brownish and mainly localized in the nuclei of 
cancer cells. In the focus tissue of EC, strong immunostaining  
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Figure 1  Relative expression of pol mRNA in samples. P-value of less 
than 0.05 was considered as significant.  
signal was present in the front of invasive malignant cells 
with pleomorphism, in particular giant neoplastic cells with 
multinuclei, and relatively weaker signals were located in 
the cancer pearl cells. In matched normal tissue, weak im-
munostaining was mainly localized in the basal cells of epi-
thelium (Figure 2). The positive expression rate of pol 
protein was 100% in 114 EC and the matched adjacent 
normal tissue samples. The strong positive rate of pol pro-
tein was 44.73% in EC samples, significantly higher than 
that in the matched adjacent esophageal tissue samples. 
Furthermore, the strong positive rate of pol protein was 
66.67% in EC with lymph node metastasis, with a signifi-
cant increase compared with EC without lymph node in-
volvement (Table 1).  
2.3  Survival analysis of EC patients 
Kaplan-Meier survival curve was plotted through sorting the  
follow-up data of the 114 patients, to analyze the relationship 
between the expression of pol and age, sex, or lymph node 
metastasis. Log-rank test revealed a significant difference in 
survival between subjects with and without lymph node 
metastasis (2=12.681, P<0.001, Figure 3(a)) and between 
those with +, ++ and +++ in pol protein expression (2= 
59.987, P<0.001, Figure 3(b)), but no statistical difference 
was found between those with different sexes (2=1.263, P= 
0.261, Figure 3(c)) or ages (60 years and <60 years) (2= 
1.179, P=0.278, Figure 3(d)).    
COX univariate regression analysis suggested the risk 
factors in survival of esophageal cancer patients included 
the presence of lymph node metastasis (Wald 2=11.872, 
P=0.001)and the high expression in either pol mRNA 
(Wald 2=93.734, P<0.001) or pol protein(Wald 2= 45.069, 
P<0.001), but not sex (Wald 2=1.219, P=0.270) or age  
 
Figure 2  Immunohistochemistry staining of pol in EC and matched 
adjacent esophageal tissue. Adjacent normal esophageal tissue (+) (a). EC 
of lower invasion showed weaker yellow signals (+) (b). EC of mean inva-
sion showed brownish signals (++) (c), EC of higher invasion (d) showed 
strong brownish signals (+++). Bar=500 m. 
Table 1  Expression of pol protein in EC and adjacent esophageal tissue  
Groups N 
Pol protein Strong positive  
expression rate(%) 
P-value 
– + ++ +++ 
Adjacent normal tissue  114 0 101 13 0 0.00  
EC  114 0 9 54 51 44.73 ＜0.001  
Age(years)        
60 51 0 3 27 21 39.62  
<60 63 0 6 27 30 47.62 0.608 
Gender        
Male 53 0 3 27 23 43.40  
Female 61 0 6 27 28 45.90 0.937 
Lymph node metastasis         
Yes 45 0 0 15 30 66.67  
No  69 0 9 39 21 30.43 ＜0.001   
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Figure 3  Survival analysis of EC patients. Comparison of survival curve between esophageal cancer patients with and without lymph node metastasis (a). 
Comparison of survival curve between esophageal cancer patients different in protein expression (b). Comparison of survival curve between esophageal 
cancer patients different in sex (c) and in age (d).  
(Wald 2=1.135, P=0.287). COX multivariate regression 
analysis further proved that the risk factors in survival of 
esophageal cancer patients included the presence of lymph 
node metastasis (Wald 2=12.370, P<0.001) and the high 
expression in either pol mRNA (Wald 2=111.934, P< 
0.001) or pol protein (Wald 2=47.046, P<0.001), but not 
sex or age.  
3  Discussion  
DNA pol, the core of the base excision system, exists 
widely within nucleus of mammalian cells, it works as a 
lyase capable of splitting the deoxynucleotide residue at the 
5′ end (5′dRP) and synthesizes the deoxynucleotide breach 
formed after base excision. DNA pol normal biological 
condition remains a low and permanent level, with the main 
function of reparation. Based on previous research, DNA 
pol has the indispensable action in repairing endogenous 
DNA oxidative damage, spontaneous depurination and depy-
rimidine, and DNA base damage induced by exogenous 
harms [13–15]. Early observations indicated the overex-
pression of pol in some cancers [16–18]. Albertella and 
co-workers used expression arrays to study systematically 
the expression patterns of BER (base excision repair) DNA 
polymerases in cancer cells [11]. They found that the major 
BER DNA polymerase, pol, was overexpressed in ap-
proximately one-third of all tumors sampled and pol was 
most frequently overexpressed in cancers in vivo of uterus, 
ovary, prostate and stomach.  
Our group has carried out series of researches focused on 
expression of DNA pol in esophageal cancer, and one of 
our findings is the high expression of pol in esophageal 
tumors, which correlates to drug-resistance of this malig-
nancy [19–22]. In this research, we analyzed the clinical 
and pathological significance of pol as well as its correla-
tion to survival of the patients, through testing its expression 
in both esophageal tumors and the matched normal tissues 
adjacent to tumor. RT-qPCR and protein IHC found a sig-
nificantly higher expression of pol in esophageal tumor 
than in its matched adjacent esophageal tissue, and higher 
expression of pol mRNA with significance in esophageal 
tumors with lymph node metastasis than in those without it. 
Logistic regression implied the relative expression of pol 
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mRNA to be the risk factor of lymph node metastasis of the 
patients. 100% of positive expression of pol protein was 
observed in either esophageal tumors or the matched normal 
tissues. The rate of the strong positive of pol protein ex-
pression was 44.73% in the esophageal tumor, higher statis-
tically than that in the matched normal tissue. In the 45 tu-
mors with lymph node metastasis, the rate of 66.67% of the 
strong positive of pol protein expression was noticed, sig-
nificantly higher than the 30.43% observed in the 69 tumors 
without the metastasis. Kaplan-Meier survival analysis was 
made, based on follow up of the 114 subjects with esopha-
geal cancer. Log-rank test revealed the significant differ-
ence in survival curve either between patients with the 
lymph node metastasis and those without it, or between pa-
tients with different levels (+, ++ and +++) of positive ex-
pression of pol protein, but not between groups different in 
sex or ages (60 years and <60 years). Based on COX uni-
variate or multivariate regression analysis, the risk factors 
of survival of esophageal cancer patients were considered to 
be the presence of metastasis, level of pol mRNA expres-
sion and pol protein, but not sex or age.  
These findings suggest the probable improvement of on-
cogenesis and development by DNA pol in esophageal 
cancer, which may be explained by the overly expressed 
pol alters the distribution of normal functions and active 
status of various DNA pol. The DNA pol existing in high 
percentage will replace other DNA polymerases and fulfills 
its function of DNA polymerization, which is its minor ac-
tion, to participate in DNA replication. Given its poor fidel-
ity in replication without text-proofing, the overly expressed 
will lead to the replication with errors of genes mediating 
cell cycle and the accumulation of mutations in a static cell 
[23]. Meanwhile, mutual action between the highly ex-
pressed DNA pol and telomeric repeat binding factor2 
(TRF2) will disturb the function of telomeres and the melt-
ed ends of chromosomes, thereby raising the hereditary in-
stability, increasing the spontaneous mutation rate and pro-
moting oncogenesis [24]. High expression of pol in esopha-
geal cancers is often accompanied with mutation of pol, 
which lowers the sensitivity of the malignancy to radio-
therapy and chemotherapy [25–28]. Maybe it is another 
important reason of the influenced development of esopha-
geal and survival by the expression level of DNA pol.  
In short, our results imply that overexpression of DNA 
pol may be a potential bio-marker in favor of early-stage 
diagnosis and indicating the poor prognosis in human 
esophageal cancer. Though a clue is provided for oncogene-
sis and development of this malignancy, this research is 
limited by the small sample size used in analysis on DNA 
pol expression and follow. Our successive research based 
on a larger sample is still needed to elucidate the mecha-
nism of pol in esophageal cancer, and therefore provide a 
basis for the controlled expression of pol within the proper 
range, inhibition of the development of esophageal cancer, 
and improved efficacy of radiotherapy and chemotherapy.  
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